Autonomix Medical Inc（AMIX）宣布，其已顺利完成符合优良实验室规范（GLP）的临床前研究。这一里程碑式的进展，标志着该公司在向美国食品药品监督管理局（FDA）提交正式申请的道路上，踏出了至关重要的一步。
Autonomix Medical Inc（AMIX）宣布，其已顺利完成符合优良实验室规范（GLP）的临床前研究。这一里程碑式的进展，标志着该公司在向美国食品药品监督管理局（FDA）提交正式申请的道路上，踏出了至关重要的一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.